StonvexLoading…
StonvexStonvexStonvexCore line items from CBU's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $818.01M | $746.30M | $652.12M | $679.36M |
Operating Income | $275.39M | $236.71M | $168.23M | $240.31M |
Net Income | $210.46M | $182.48M | $131.92M | $188.08M |
EPS (Diluted) | $3.97 | $3.44 | $2.45 | $3.46 |
Total Assets | $17.30B | $16.39B | $15.56B | $15.84B |
Total Liabilities | $15.30B | $14.62B | $13.86B | $14.28B |
Cash & Equivalents | $301.75M | $197.00M | $190.96M | $209.90M |
Free Cash Flow OCF − CapEx | $233.33M | $221.57M | $209.84M | $201.68M |
Shares Outstanding | 52.82M | 52.88M | 53.73M | 54.21M |